TAVR for Severe Aortic Stenosis
Severe symptomatic aortic stenosis carries a poor prognosis untreated. How transcatheter aortic valve replacement changed the options, and who it suits.
TAVR
Transcatheter aortic valve replacement has moved from inoperable rescue to a mainstream option across surgical risk categories, and the PARTNER and Evolut programmes drive much of that story. Articles here cover CT-based annular sizing and access planning, valve platform selection, coronary access and the lifetime management question in younger patients, conduction disturbance and pacemaker need, paravalvular regurgitation, stroke protection, and valve durability with structural deterioration. Bicuspid anatomy, low-flow low-gradient physiology, valve-in-valve procedures and antithrombotic strategy after implantation are addressed. Structural operators will find our interventional and acute care titles and the expert cardiologist bundle useful companions.